Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex

51Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

The biological basis for the therapeutic mechanisms of depression is still unknown. We have previously performed expressed-sequence tag (EST) analysis to identify some molecular machinery responsible for antidepressant effect. Then, we developed our original cDNA microarray, on which cDNA fragments identified as antidepressant-related genes/ESTs were spotted. In this study, with this microarray followed by Western blot analysis, we have demonstrated the induction of vesicle-associated membrane protein 2 (VAMP2/synaptobrevin-2) in rat frontal cortex not only after chronic antidepressant treatment, but also after repated electroconvulsive treatment. On the other hand, expression of SNAP-25 and syntaxin-1 was not changed by these treatments. These components make a soluble N- ethylmaleimide-sensitive fusion protein attachment protein receptor complex with VAMP2 and mediate the synaptic vesicle docking/fusion machiner. In conclusion, it is suggested that VAM2/synaptobrevin-2 plays important roles in the antidepressant effects. Our results may contribute to a novel model for the therapeutic mechamism of depression and new molecular targets for the development therapeutic agents.

Cite

CITATION STYLE

APA

Yamada, M., Takahashi, K., Tsunoda, M., Nishioka, G., Kudo, K., Ohata, H., … Yamada, M. (2002). Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex. Pharmacogenomics Journal, 2(6), 377–382. https://doi.org/10.1038/sj.tpj.6500135

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free